tradingkey.logo
tradingkey.logo
Search

Corcept Therapeutics Inc

CORT
Add to Watchlist
114.490USD
-3.830-3.24%
Close 07-31 16:00ETQuotes delayed by 15 min
12.38BMarket Cap
249.99P/E TTM

CORT Financials

See Corcept Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Corcept Therapeutics Inc Earnings Date

Latest Release
Jul 29, 2026
EPS / Forecast
0.41/0.01
Revenue / Forecast
256.15M/219.99M
Period
FY2025 Earnings
Revenue(YoY)
761.41M
12.79%
EPS(YoY)
0.96
-29.86%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
20.83%0.41
-254.09%-0.30
-21.04%0.23
-58.41%0.19
-1.90%0.34
-26.92%0.20
-3.08%0.30
48.49%0.46
27.47%0.34
83.50%0.27
98.59%0.31
--0.31
--0.27
--0.15
--0.15
----
----
----
----
----
Revenue
31.74%256.15M
4.89%164.90M
11.12%202.13M
13.75%207.64M
18.70%194.43M
7.09%157.21M
34.33%181.89M
47.69%182.55M
39.15%163.80M
38.95%146.81M
31.39%135.41M
21.50%123.60M
13.86%117.72M
12.77%105.65M
4.28%103.06M
5.82%101.73M
12.88%103.39M
17.94%93.69M
15.26%98.82M
11.36%96.13M
Net Profit
22.30%42.99M
-254.58%-31.76M
-21.00%24.29M
-58.34%19.67M
-0.96%35.15M
-25.99%20.55M
-1.94%30.75M
50.47%47.21M
28.92%35.49M
74.83%27.76M
88.87%31.36M
-9.33%31.38M
0.42%27.53M
-30.35%15.88M
-48.21%16.60M
13.58%34.61M
3.35%27.41M
-2.85%22.80M
23.31%32.05M
40.91%30.47M
Net Margin
-7.17%16.78%
-247.37%-19.26%
-28.91%12.02%
-63.38%9.47%
-16.56%18.08%
-30.89%13.07%
-27.00%16.90%
1.88%25.86%
-7.35%21.67%
25.82%18.91%
43.75%23.16%
--25.39%
--23.39%
--15.03%
--16.11%
----
----
----
----
----
Gross Margin
0.18%98.41%
-0.22%98.25%
0.37%98.74%
-0.65%97.79%
-0.23%98.23%
0.20%98.47%
-0.24%98.37%
-0.24%98.43%
-0.21%98.46%
-0.42%98.27%
0.05%98.61%
--98.67%
--98.66%
--98.69%
--98.56%
----
----
----
----
----
Revenue
31.74%256.15M
4.89%164.90M
11.12%202.13M
13.75%207.64M
18.70%194.43M
7.09%157.21M
34.33%181.89M
47.69%182.55M
39.15%163.80M
38.95%146.81M
31.39%135.41M
21.50%123.60M
13.86%117.72M
12.77%105.65M
4.28%103.06M
5.82%101.73M
12.88%103.39M
17.94%93.69M
15.26%98.82M
11.36%96.13M
Operating profit
54.83%41.30M
-1552.02%-49.60M
-82.24%4.49M
-78.07%10.22M
-25.05%26.68M
-88.42%3.42M
-20.23%25.26M
49.46%46.60M
20.31%35.59M
98.61%29.50M
40.76%31.67M
-2.37%31.18M
-5.88%29.58M
-44.51%14.85M
-38.63%22.50M
-11.86%31.93M
-1.60%31.43M
36.31%26.77M
20.17%36.66M
46.58%36.23M
Net Profit
22.30%42.99M
-254.58%-31.76M
-21.00%24.29M
-58.34%19.67M
-0.96%35.15M
-25.99%20.55M
-1.94%30.75M
50.47%47.21M
28.92%35.49M
74.83%27.76M
88.87%31.36M
-9.33%31.38M
0.42%27.53M
-30.35%15.88M
-48.21%16.60M
13.58%34.61M
3.35%27.41M
-2.85%22.80M
23.31%32.05M
40.91%30.47M
Current assets
-0.78%439.68M
-2.84%426.03M
2.94%485.46M
15.88%541.13M
-20.99%443.11M
-12.89%438.50M
2.83%471.60M
8.22%466.98M
29.65%560.85M
-5.72%503.37M
-8.14%458.64M
-4.61%431.53M
3.23%432.59M
37.52%533.89M
87.36%499.25M
12.57%452.40M
1.89%419.05M
-5.23%388.22M
-44.31%266.46M
-13.29%401.90M
Total current liabilities
6.32%153.80M
4.28%149.19M
17.98%166.09M
36.48%172.26M
43.59%144.66M
47.18%143.07M
34.70%140.77M
3.56%126.22M
8.26%100.75M
23.25%97.20M
44.16%104.50M
129.65%121.87M
89.70%93.06M
37.77%78.86M
52.48%72.49M
18.57%53.07M
8.05%49.06M
40.99%57.24M
0.10%47.54M
3.97%44.76M
Total assets
10.85%888.70M
-3.73%814.88M
-0.46%836.65M
5.02%823.61M
12.20%801.72M
29.05%846.46M
35.24%840.55M
32.02%784.26M
36.20%714.55M
6.16%655.93M
6.53%621.52M
11.40%594.02M
5.69%524.63M
31.98%617.85M
37.68%583.43M
-8.91%533.25M
-12.69%496.36M
-15.26%468.12M
-25.88%423.76M
9.60%585.40M
Total liabilities
10.24%182.93M
8.41%176.89M
17.32%188.85M
31.83%191.71M
40.25%165.93M
50.98%163.17M
40.20%160.96M
9.88%145.42M
14.85%118.31M
22.44%108.07M
40.72%114.81M
120.97%132.34M
90.63%103.01M
46.35%88.26M
70.15%81.59M
32.59%59.89M
17.97%54.04M
44.99%60.31M
-0.92%47.95M
1.63%45.17M
Total equity
11.01%705.78M
-6.63%637.99M
-4.68%647.80M
-1.09%631.90M
6.63%635.79M
24.72%683.28M
34.12%679.59M
38.37%638.84M
41.42%596.24M
3.45%547.86M
0.97%506.70M
-2.47%461.68M
-4.68%421.61M
29.86%529.58M
33.54%501.84M
-12.38%473.36M
-15.37%442.33M
-20.16%407.81M
-28.19%375.81M
10.32%540.23M
Net operating income
-23.66%33.54M
-427.07%-16.77M
-35.16%38.45M
-26.21%54.48M
6.69%43.94M
-78.41%5.13M
907.30%59.30M
39.54%73.83M
-2.61%41.18M
-8.48%23.76M
-82.37%5.89M
57.24%52.91M
134.40%42.29M
-26.36%25.96M
-32.45%33.39M
-30.91%33.65M
-59.31%18.04M
38.65%35.25M
40.93%49.43M
59.98%48.70M
Net investment
-141.70%-29.24M
243.24%4.54M
81.60%-11.84M
133.26%14.64M
216.50%70.13M
64.82%-3.17M
-476.42%-64.36M
59.81%-44.04M
-149.80%-60.19M
-104.34%-9.01M
199.17%17.10M
-2187.47%-109.57M
42.35%-24.10M
510.87%207.47M
-112.27%-17.24M
81.44%-4.79M
-268.94%-41.80M
-1437.64%-50.50M
1151.97%140.47M
59.85%-25.80M
Net financing
98.02%-2.04M
101.91%760.00K
-583.96%-31.22M
-120.05%-46.41M
-4687.63%-102.93M
-7230.20%-39.80M
-695.82%-4.56M
-438.61%-21.09M
98.52%-2.15M
-400.00%-543.00K
1355.74%766.00K
71.95%-3.92M
-5188.61%-145.75M
135.77%181.00K
99.97%-61.00K
40.95%-13.96M
89.41%-2.76M
98.90%-506.00K
-31211.50%-206.97M
-503.05%-23.64M

FAQs

What is the total revenue of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its total revenue reached 761.41M, with a year-on-year change of 675.04M.

What are the current assets of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its current assets were 485.46M, with a year-on-year change of 2.94.

What are the total assets of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its total assets of Corcept Therapeutics Inc were 836.65M, with a year-on-year change of -0.46.

What are the total liabilities of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its total liabilities of Corcept Therapeutics Inc were 188.85M, with a year-on-year change of 17.32.

What is the total equity of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its total equity of Corcept Therapeutics Inc was 647.80M, with a year-on-year change of -4.68.

What is the net operating income of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its net operating income of Corcept Therapeutics Inc was 44.80M, with a year-on-year change of -67.29.

What is the net investment of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its net investment of Corcept Therapeutics Inc was 69.76M, with a year-on-year change of 139.28.

What is the net financing of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its net financing of Corcept Therapeutics Inc was -220.37M, with a year-on-year change of -677.33.

What is the Earnings Per Share (EPS) of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.96, with a year-on-year change of -29.86.

What is the net income of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its net income was 99.65M, with a year-on-year change of -29.43.

What is the net margin of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its net profit margin was 13.09, with a year-on-year change of -37.43.

What is the gross margin of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its gross margin was 98.30, with a year-on-year change of -0.09.

What is the Return on Equity (ROE) of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was 15.01, with a year-on-year change of -36.93.

What is the Return on Assets (ROA) of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was 11.88, with a year-on-year change of -38.48.

What is the operating profit of Corcept Therapeutics Inc?

According to Corcept Therapeutics Inc's FY2025 earnings report, its operating profit was 44.80M, with a year-on-year change of -67.29.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.